MajorOther opioids×Fixed-dose combination: weak opioid with SNRI activity plus non-opioid analgesic
Updated · Methodology
Mechanism
Tramadol/paracetamol contains the same substance, tramadol: each tablet has 37.5 mg of tramadol and 325 mg of paracetamol (tramadol/paracetamol summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 2). When the combination is taken with another tramadol product, the tramadol doses add up, and the daily dose can exceed the ceiling. The ceiling is 8 tablets a day (300 mg of tramadol) for the combination and 400 mg a day for tramadol (tramadol/paracetamol and tramadol SmPCs, AEMPS, section 4.2). Above the recommended doses, the risk of seizures may rise (tramadol and tramadol/paracetamol SmPCs, AEMPS, section 4.4). Tramadol overdose depresses the central nervous system and breathing and causes seizures and serotonin syndrome (tramadol and tramadol/paracetamol SmPCs, AEMPS, section 4.9). For this reason, the US labels of both products state explicitly that they are not to be used with other tramadol-containing products (tramadol/acetaminophen and tramadol labels, US Food and Drug Administration, FDA, section 2.1).
Symptoms
The main risk of the combination is tramadol overdose. Its signs are pinpoint pupils, vomiting and seizures. Blood pressure can fall as far as circulatory collapse, impaired consciousness can progress to coma, and respiratory depression can progress to respiratory arrest. Serotonin syndrome has also been reported (tramadol and tramadol/paracetamol summaries of product characteristics, SmPCs, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.9). General signs of opioid toxicity are confusion, drowsiness, shallow breathing, nausea and vomiting (tramadol/paracetamol SmPC, AEMPS, section 4.4). Seizures can occur even at recommended doses, and the risk may rise above the ceiling of 400 mg a day (tramadol SmPC, AEMPS, section 4.4).
Management
Under the US labels, tramadol/paracetamol and tramadol are not used together with other tramadol-containing products (tramadol/acetaminophen and tramadol labels, US Food and Drug Administration, FDA, section 2.1). In Spain, patients are warned not to exceed the recommended dose of the combination and not to take other tramadol products with it without a doctor's recommendation (tramadol/paracetamol summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.4). The maximum dose of the combination is 8 tablets a day, that is 300 mg of tramadol and 2600 mg of paracetamol, with at least 6 hours between doses (AEMPS, section 4.2). The daily dose of tramadol should not exceed 400 mg except in special clinical circumstances, because the risk of seizures may rise above this ceiling (tramadol SmPC, AEMPS, sections 4.2 and 4.4; tramadol FDA label, section 2.1). Overestimating the dose of the combination when converting a patient from another opioid can cause a fatal overdose with the first dose (tramadol/acetaminophen FDA label, section 5.2). The FDA advises telling patients and carers about opioid overdose reversal agents, naloxone and nalmefene (tramadol/acetaminophen FDA label, section 2.2). In overdose, breathing and circulation are supported, respiratory depression is reversed with naloxone, and seizures are treated with intravenous diazepam (tramadol SmPC, AEMPS, section 4.9).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- FDA: Tramadol hydrochloride tablets prescribing information (Amneal) (2026)– FDA label, Amneal Pharmaceuticals NY LLC, DailyMed setid 8ec4e4e5-a56e-4198-8428-6b770b9bf27d, revised 06/2026, sections 4, 5.9, 5.10, 7 and 17
- AEMPS: Ficha técnica: Tramadol, Adolonta 50 mg cápsulas (nº registro 59088), sección 4.5 (2025)– AEMPS, CIMA, nº registro 59088, revisión 11/2025, secciones 4.2, 4.4 y 4.5
- AEMPS: Ficha técnica: Tramadol/Paracetamol, Zaldiar 37,5 mg/325 mg (nº registro 65149), sección 4.5 (2026)– AEMPS, CIMA, nº registro 65149 (Zaldiar 37,5 mg/325 mg comprimidos recubiertos con película, Grünenthal Pharma), revisión 02/2026, secciones 4.2, 4.3, 4.4, 4.5 y 4.9
- FDA: Tramadol hydrochloride and acetaminophen tablets (Amneal) prescribing information (2026)– FDA, DailyMed setid d51600e2-2f73-483c-9b2e-f142bafff16d (Amneal Pharmaceuticals of New York), versión 34, efectiva 01/2026, Boxed Warning, secciones 5.3, 5.10, 5.11 y 7